1h Free Analyst Time
The sulphonamides market is poised to grow by $128.42 mn during 2022-2026, accelerating at a CAGR of 4.68% during the forecast period. The report on the sulphonamides market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of infectious diseases, rising urinary tract infections among individuals, and special regulatory designations.
The sulphonamides market analysis includes formulation segment and geographic landscape.
The sulphonamides market is segmented as below:
By Formulation
- Oral
- Topical
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- The Middle East and Africa
This study identifies the growing awareness of various diseases and their treatment as one of the prime reasons driving the sulphonamides market growth during the next few years. Also, strategic alliances and mergers and acquisitions (M&A) and increased federal and institutional funding for antibiotic research will lead to sizable demand in the market.
The report on the sulphonamides market covers the following areas:
- Sulphonamides market sizing
- Sulphonamides market forecast
- Sulphonamides market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sulphonamides market vendors that include AA Pharma Inc., Abbott Laboratories, Agron Remedies Pvt. Ltd., Amneal Pharmaceuticals Inc., C. H. Boehringer Sohn AG, and Co. KG, Cadila Pharmaceuticals Ltd., Cipla Ltd., Dhanuka Agritech Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lexine Technochem Pvt. Ltd., Novartis AG, PANPHARMA S.A., Pfizer Inc., Sanofi, Smilax Laboratories Ltd., Stedman Pharmaceuticals Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd. Also, the sulphonamides market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Formulation
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global sulphonamides market: AA Pharma Inc., Abbott Laboratories, Agron Remedies Pvt. Ltd., Amneal Pharmaceuticals Inc., C. H. Boehringer Sohn AG, and Co. KG, Cadila Pharmaceuticals Ltd., Cipla Ltd., Dhanuka Agritech Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lexine Technochem Pvt. Ltd., Novartis AG, PANPHARMA S.A., Pfizer Inc., Sanofi, Smilax Laboratories Ltd., Stedman Pharmaceuticals Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing awareness of various diseases and their treatment.`
According to the report, one of the major drivers for this market is the rising prevalence of infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AA Pharma Inc.
- Abbott Laboratories
- Agron Remedies Pvt. Ltd.
- Amneal Pharmaceuticals Inc.
- C. H. Boehringer Sohn AG and Co. KG
- Cadila Pharmaceuticals Ltd.
- Cipla Ltd.
- Dhanuka Agritech Ltd.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Lexine Technochem Pvt. Ltd.
- Novartis AG
- PANPHARMA S.A.
- Pfizer Inc.
- Sanofi
- Smilax Laboratories Ltd.
- Stedman Pharmaceuticals Pvt. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Zydus Lifesciences Ltd.